









Chemicals in Breast Milk
Little Data to Date
Breast milk offers infants unparalleled nutrition to fuel their growth
and development. It also provides a host of immune factors that
can increase their resistance to common infections. Additionally,
breast-fed infants may have a reduced risk of developing chronic
diseases such as diabetes, allergies, and asthma. By breast-feeding
her infant, a mother herself receives several health benefits, includ-
ing less postpartum bleeding, a quicker return to prepregnancy
weight, and a potentially decreased risk of ovarian and breast can-
cers. However, some new mothers hesitate to breast-feed due to
concern about environmental chemicals in their breast milk.
Although the benefits of breast-feeding outweigh the risks of low-
level chemical exposures, more information is necessary to dispel
concerns.
In a review of the literature on environmental chemicals in breast
milk, Judy S. LaKind and colleagues from the Pennsylvania State
University College of Medicine and the Johns Hopkins University
Department of Mathematical Sciences demonstrate that the data,
particularly in the United States, are sparse [EHP 109:75–88]. Their
review focuses on two aspects of exposure: chemical concentrations in
breast milk and their trends over time. 
Environmental contaminants such as polychlorinated dioxins and
furans, polychlorinated biphenyls, and chlorinated organic pesticides
have been detected at low concentrations in breast milk throughout
the world. Among other risks, these chemicals are suspected of subtly
damaging the immune system, causing developmental delays, and
increasing an exposed person’s lifetime cancer risk. The chemicals,
which accumulate in body fat over the course of a person’s life, are
mobilized during lactation and excreted in breast milk. 
LaKind and her associates identify several problems that impede
the forming of general conclusions. In the United States, there are
uncertainties regarding whether breast milk samples have been col-
lected in a way that allows for comparison from one study to another,
and the data that exist pertain only to a limited number of women
from specific locations. Data from other nations, particularly in
Europe, are more thorough, but, as with the data from the United
States, cross-study comparisons are difficult because of inconsistent
protocols and nonreported information. One variable that is particu-
larly overlooked is depuration (the elimination of environmental
chemicals from the mother’s body through breast milk) over the
course of lactation. Among other factors, depuration may be influ-
enced by a mother’s age, how many children she’s had, and how
much milk her infant consumes. One-time samples therefore do not
account for changes in breast milk concentrations over the course of
lactation.
The reviewers suggest that the inadequacies of current data could
be addressed through a carefully planned and coordinated breast milk
monitoring effort. Such a monitoring program could include women
from throughout the United States and could represent diverse
socioeconomic and demographic groups. Data collection could build
on earlier studies by including both previously studied chemicals as
well as other environmental contaminants such as heavy metals. 
To control for depuration differences, milk samples could be col-
lected longitudinally. Finally, to extract the maximum information
from the data, sampling and testing methods would have to be in
harmony across different studies. According to LaKind and her col-
leagues, a well-planned monitoring program would provide reliable
information to doctors, nurses, and lactation specialists, and help
them communicate the benefits of breast-feeding to new mothers.
It is also necessary, the reviewers say, to assess the concentrations
of environmental contaminants in other infant food sources, such as
formula, in order to compare the risks and benefits associated with all
sources of infant nutrition. –Julia R. Barrett
A Toxic Form of Expression
Different Agents Affect Different Genes
Toxicogenomics is a topic of great current interest. A quick scan of the
contents of any scientific journal is likely to turn up several articles on
the closely related topics of expression profiling, proteomics, toxico-
genomics, and bioinformatics. Toxicologists are intensely interested in
expression profiling—monitoring and comparing the expression of
hundreds or thousands of genes simultaneously—because this approach,
once fully developed and validated, could provide an alternative to tradi-
tional toxicologic animal bioassays that would be much faster, less cost-
ly, more sensitive and informative, and nonanimal-based.
A study in this month’s issue examines gene expression in mouse
liver using a DNA microarray that includes 148 mouse genes pre-
sumed to play a role in response to environmental exposure [EHP
109:71–74]. These genes play roles in phase I and phase II metabo-
lism, DNA repair, stress response, cell signaling, and housekeeping.
Led by Matthew Bartosiewicz, a graduate student in the molecular
biology laboratory of Alan Buckpitt at the University of California at
Davis, a team of researchers analyzed the transcriptional profile of
mice exposed to a range of doses of cadmium chloride,
benzo(a)pyrene, or trichloroethylene, three environmental/occupa-
tional contaminants that fall into distinct chemical classes. The goal
was to test the hypothesis that chemicals of different classes have dis-
tinct profiles to determine how useful the technique might be in
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Consuming questions. A review of the literature shows that data on
chemicals in breast milk are limited at best.future toxicology testing. The authors chose a small subset of mouse
genes and a small number of compounds because they consider this
study to be a “proof of principle” experiment. 
The group’s results clearly show that a distinct set of genes is induced
and/or repressed in mice exposed to these three agents. A statistically sig-
nificant change in expression was observed for 16 of the 148 genes in the
DNA microarray. The authors believe their findings provide proof that
“these three environmental contaminants . . . elicit unique patterns of
gene expression over the doses tested in an in vivo model.” 
This in vivo work confirms several earlier, comprehensive DNA
microarray studies that have been carried out based on the complete
genome sequence of Saccharomyces cerevisiae, which have established
that DNA microarray technology can provide quantitative informa-
tion on changes in gene expression due to altered cellular environ-
ment, disease, and/or exposure to stress. The present study by
Bartosiewicz and colleagues is a promising demonstration that envi-
ronmentally important agents can be monitored using DNA
microarray technology in an in vivo mammalian system. Due to
these efforts, the groundwork is steadily being laid for future use of
expression profiling in toxicology testing. 
Although the patterns of gene induction in this study largely
agree with those found in earlier studies, there were some differ-
ences for genes that had previously been up-regulated in association
with benzo(a)pyrene. Future work will determine if these differ-
ences are due to differences between in vivo and in vitro experimen-
tal systems, or tissue or dose specificity. –Miriam Sander
Empty Nets?
Fishing for Hard Facts on Pfiesteria
Pfiesteria piscicida and related toxic dinoflagellates were implicated in
numerous fish kills in Atlantic coast estuaries in the 1990s, raising
concerns about possible threats to public health. In 1997, Maryland
watermen reported health effects from environmental exposure to
toxic Pfiesteria, including memory loss and confusion. North
Carolina also recorded many Pfiesteria-related fish kills, but
researchers there had not systematically studied health effects among
people who were exposed to waterways where Pfiesteria and related
toxic dinoflagellates could occur. 
In this issue, Marian Swinker of the East Carolina University
School of Medicine and colleagues report on the first
comprehensive examination in North Carolina of
people with long-term contact with waterways where
they may encounter Pfiesteria [EHP 106:21–26].
Conducted at the request of the state health agency
in November 1997, the study found no pattern of
abnormalities that could be attributed to possible
exposure to Pfiesteria and related dinoflagellates.
It is difficult to assess whether someone has experi-
enced contact with Pfiesteria. This dinoflagellate, which
inhabits estuaries, spends nearly all of its time in non-
toxic life stages. Moreover, the dinoflagellate attacks
fish suddenly and then retreats, returning quickly to a
nontoxic form on the estuary bottom. To confuse the
issue, toxic algae such as Pfiesteria are not the primary
cause of fish kills in estuarine waters; instead, low oxy-
gen concentrations commonly kill large numbers of
fish in shallow estuaries during warm months. As a
consequence of these factors, biologists have had diffi-
culty tracking the dinoflagellate and determining
whether it actually is the cause of many fish kills, even
in places where the organism has been found. 
In their study, the North Carolina team used the 1997 Centers
for Disease Control and Prevention case description for estuary-
associated syndrome (EAS). This case description covers anyone
who complains of persistent health effects such as memory loss,
confusion, or acute skin burning after recent or remote contact with
fish kills, fish with lesions, or affected waterways. For the North
Carolina study, the term “affected waterways” could mean one of
three things: any estuarine areas with conditions conducive to a
Pfiesteria outbreak, any area where diseased fish were reported from
June to September 1997, or any area where Pfiesteria had been seen
in the past. 
The team examined 22 licensed commercial fishermen and state
employees who had worked in such waterways. Seventeen of the
fishermen in this group reported exposure to a fish kill or to fish
with lesions—possibly, but not conclusively, caused by Pfiesteria.
For controls, the team examined 21 watermen and state employees
who worked in the ocean, where Pfiesteria cannot survive. Eleven of
those in the control group reported exposure to a fish kill or to fish
with lesions that could not have been caused by Pfiesteria. 
The team’s examinations included a medical, occupational, and
environmental history; general medical, dermatologic, and neuro-
logic examinations; vision testing; and neuropsychologic evalua-
tions. One subject in each group had had symptoms of EAS in the
past, but neither subject had significant and current neuropsycho-
logic impairment when examined. 
The team found no pattern of abnormalities in these evalua-
tions, with one exception. Watermen who worked on affected
waterways had a significant reduction in a visual contrast sensitivity
test—a measurement of the ability to detect visual patterns.
Neurotoxins can affect vision, including the ability to detect visual
patterns. But certain chemicals, drugs, alcohol, and several develop-
mental and degenerative conditions can have the same effect.
Moreover, scientists have not determined whether visual contrast
sensitivity is affected by known dinoflagellate toxins. The
researchers point out that there is no evidence that a relationship
exists between potential environmental exposure to Pfiesteria or
related toxic dinoflagellates and a reduction in visual contrast sensi-
tivity, but that such reduced sensitivity should be considered in
future studies to assess whether it might act as a marker of toxic
dinoflagellate exposure. –John Tibbetts
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Casting about for answers. A North Carolina study found no link between health
effects and exposure to toxic Pfiesteria.